Related Experiment Video
Updated: Jan 2, 2026
05:28
Standard Membrane Feeding Assay for the Detection of Plasmodium falciparum Infection in Anopheles Mosquito Vectors
Published on: May 12, 2022
3.5K
Malaria drug-sensitivity testing: new assays, new perspectives
Harald Noedl1, Chansuda Wongsrichanalai, Walther H Wernsdorfer
1Dept of Specific Prophylaxis and Tropical Medicine, Institute of Pathophysiology, University of Vienna, Kinderspitalgasse 15, A-1095, Vienna, Austria. harald.noedl@univie.ac.at <harald.noedl@univie.ac.at>
Trends in Parasitology
|April 12, 2003
Summary
Drug resistance in Plasmodium falciparum is a major concern. This review covers new in vitro assays for faster malaria drug sensitivity testing and surveillance, evaluating their effectiveness and limitations.
Area of Science:
- Tropical medicine
- Parasitology
- Pharmacology
Background:
- Plasmodium falciparum drug resistance has escalated over five decades, posing a significant global health challenge.
- In vitro antimalarial drug sensitivity assays are crucial for monitoring resistance and informing treatment strategies.
- Existing assays face challenges in speed and ease of use, necessitating advancements.
Purpose of the Study:
- To review and analyze novel in vitro assay methodologies for assessing malaria drug sensitivity.
- To evaluate the advantages, limitations, and potential applications of these new approaches.
- To provide insights into the future of antimalarial drug resistance surveillance and drug discovery.
Main Methods:
- Comprehensive literature review of recent publications on in vitro antimalarial drug sensitivity assays.
- Comparative analysis of different assay types, focusing on ease of handling, speed, and accuracy.
- Examination of data on the identification of drug-resistant Plasmodium falciparum strains.
Main Results:
- Several new in vitro assays offer improved efficiency and speed compared to traditional methods.
- These assays facilitate quicker identification of drug-resistant parasites and simpler drug evaluation.
- Limitations include potential variations in performance and the need for further validation across diverse settings.
Conclusions:
- New in vitro assays represent significant progress in malaria drug sensitivity testing.
- Continued development and validation are essential for effective global surveillance of Plasmodium falciparum drug resistance.
- These tools are vital for guiding antimalarial treatment policies and accelerating new drug development.
